Compound Guides

An evidence-led explanation of GLP-1 biology, receptor signaling, approved GLP-1 receptor agonist medicines and the boundaries of research-only peptide products.

Peptides and steroids are chemically different categories. Learn how their structures, receptors and research uses differ, and why neither label implies universal safety.

Ozempic contains semaglutide, a peptide-based GLP-1 receptor agonist. Here is how its regulated drug status differs from research peptide products and generic GLP-1 terminology.

A careful overview of BPC-157 research, including what animal studies suggest, why human efficacy is not established and how laboratory buyers evaluate product identity.

KPV is a three-amino-acid peptide studied in experimental inflammation models. This guide explains the mechanisms, evidence boundaries and analytical sourcing questions.

Copper peptides are copper-binding peptide complexes. This practical guide explains GHK-Cu structure, skin biology, formulation questions and research quality limits.

A research guide to AOD-9604 covering molecular identity, its relationship to the C-terminal region of human growth hormone, published evidence and quality verification.

A scientific overview of Epithalon/Epitalon, the AEDG tetrapeptide, its relationship to Epithalamin and the evidence behind telomerase and aging-related research claims.

A research-focused guide to retatrutide, its three receptor targets, current 2026 evidence and the distinction between published clinical research and laboratory research material.

GHK-Cu is a copper-binding tripeptide system whose research interpretation depends on molecular identity, coordination state and formulation context.